Cargando…
Renal improvement and remission in a patient with refractory ANCA-associated vasculitis treated with avacopan
Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis is associated with end-organ damage resulting in significant morbidity and mortality. Most recently, avacopan, an orally administered selective antagonist of the C5a receptor, was approved by the US Food and Drug Administration as...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638159/ https://www.ncbi.nlm.nih.gov/pubmed/37036661 http://dx.doi.org/10.1007/s40620-023-01614-y |